Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: quinolone antibacterials - Procter & Gamble

Drug Profile

Research programme: quinolone antibacterials - Procter & Gamble

Alternative Names: (3S)-Amino-(4R)-ethylpiperidinyl quinolones research programme - Procter & Gamble; 5,6-Bridged dioxinoquinolones research programme - Procter & Gamble; Non-fluorinated quinolones research programme - Procter & Gamble; PGE 836779; Quinolone antibacterials research programme - Procter & Gamble

Latest Information Update: 01 Dec 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Procter & Gamble
  • Class Quinolones
  • Mechanism of Action DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Bacterial infections

Most Recent Events

  • 06 Jan 2005 TaiGen Biotechnology entered a strategic alliance with Procter & Gamble for further development and commercialisation of an unspecified, non-fluorinated quinolone invented by Procter & Gamble. TaiGen has development and commercialisation rights in China, Taiwan, Korea and the ASEAN countries
  • 07 Jan 2004 A preclinical study has been added to the Bacterial Infections antimicrobial activity section
  • 05 Sep 2003 This programme is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top